These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35417204)

  • 1. Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules.
    Manjunath Y; Suvilesh KN; Mitchem JB; Avella Patino DM; Kimchi ET; Staveley-O'Carroll KF; Pantel K; Yi H; Li G; Harris PK; Chaudhuri AA; Kaifi JT
    JCO Precis Oncol; 2022 Mar; 6():e2100378. PubMed ID: 35417204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer.
    Manjunath Y; Upparahalli SV; Suvilesh KN; Avella DM; Kimchi ET; Staveley-O'Carroll KF; Li G; Kaifi JT
    Lung Cancer; 2019 Aug; 134():147-150. PubMed ID: 31319973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in early detection of non-small cell lung cancer: A comprehensive review.
    Kenaan N; Hanna G; Sardini M; Iyoun MO; Layka K; Hannouneh ZA; Alshehabi Z
    Cancer Med; 2024 Sep; 13(18):e70156. PubMed ID: 39300939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of the PanCan Model and Lung-RADS to Assess Cancer Probability Among People With Screening-Detected, Solid Lung Nodules.
    Sundaram V; Gould MK; Nair VS
    Chest; 2021 Mar; 159(3):1273-1282. PubMed ID: 33393476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
    Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
    J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
    Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
    J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.
    Marquette CH; Boutros J; Benzaquen J; Ferreira M; Pastre J; Pison C; Padovani B; Bettayeb F; Fallet V; Guibert N; Basille D; Ilie M; Hofman V; Hofman P;
    Lancet Respir Med; 2020 Jul; 8(7):709-716. PubMed ID: 32649919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting pulmonary malignancy against benign nodules using noninvasive cell-free DNA fragmentomics assay.
    Xu S; Luo J; Tang W; Bao H; Wang J; Chang S; Zou Z; Fan X; Liu Y; Jiang C; Wu X
    ESMO Open; 2024 Aug; 9(8):103595. PubMed ID: 39088983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer screening with MRI: Evaluation of MRI for lung cancer screening by comparison of LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds.
    Meier-Schroers M; Homsi R; Gieseke J; Schild HH; Thomas D
    Eur Radiol; 2019 Feb; 29(2):898-905. PubMed ID: 29992387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
    Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
    Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.
    Wendel M; Bazhenova L; Boshuizen R; Kolatkar A; Honnatti M; Cho EH; Marrinucci D; Sandhu A; Perricone A; Thistlethwaite P; Bethel K; Nieva J; Heuvel Mv; Kuhn P
    Phys Biol; 2012 Feb; 9(1):016005. PubMed ID: 22307026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals.
    Landy R; Wang VL; Baldwin DR; Pinsky PF; Cheung LC; Castle PE; Skarzynski M; Robbins HA; Katki HA
    JAMA Netw Open; 2023 Mar; 6(3):e233273. PubMed ID: 36929398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
    Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of Radiomic Models Based on Low-Dose and Standard-Dose CT for Prediction of Adenocarcinomas and Benign Lesions in Solid Pulmonary Nodules.
    Liu J; Xu H; Qing H; Li Y; Yang X; He C; Ren J; Zhou P
    Front Oncol; 2020; 10():634298. PubMed ID: 33604303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Risk in Nodules Detected at Follow-Up Lung Cancer Screening CT.
    Hammer MM; Byrne SC
    AJR Am J Roentgenol; 2022 Apr; 218(4):634-641. PubMed ID: 34755524
    [No Abstract]   [Full Text] [Related]  

  • 16. Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of Non-smoking-related Lung Cancer.
    Hsu HT; Tang EK; Wu MT; Wu CC; Liang CH; Chen CS; Mar GY; Lai RS; Wang JC; Wu CL; Huang YL; Wu FZ
    Acad Radiol; 2018 Oct; 25(10):1240-1251. PubMed ID: 29530488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Risk in Subsolid Nodules in the National Lung Screening Trial.
    Hammer MM; Palazzo LL; Kong CY; Hunsaker AR
    Radiology; 2019 Nov; 293(2):441-448. PubMed ID: 31526256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer.
    Carlsson A; Nair VS; Luttgen MS; Keu KV; Horng G; Vasanawala M; Kolatkar A; Jamali M; Iagaru AH; Kuschner W; Loo BW; Shrager JB; Bethel K; Hoh CK; Bazhenova L; Nieva J; Kuhn P; Gambhir SS
    J Thorac Oncol; 2014 Aug; 9(8):1111-9. PubMed ID: 25157764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
    Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data.
    Hammer MM; Hunsaker AR
    AJR Am J Roentgenol; 2022 Sep; 219(3):397-405. PubMed ID: 35319912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.